AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Venuvi GM 2mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Dr Kumars Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Venuvi GM 2mg/500mg/0.3mg Tablet SR

Venuvi GM 2mg/500mg/0.3mg extended-release tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurry vision, fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function) are recommended by your doctor.

Uses of Venuvi GM 2mg/500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Venuvi GM 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Venuvi GM 2mg/500mg/0.3mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Venuvi GM 2mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Venuvi GM 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Venuvi GM 2mg/500mg/0.3mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Venuvi GM 2mg/500mg/0.3mg Tablet SR works:

The extended-release tablet, Venuvi GM, combines 2mg, 500mg, and 0.3mg of three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Venuvi GM 2mg/500mg/0.3mg SR tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Venuvi GM 2mg/500mg/0.3mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Venuvi GM tablets (2mg/500mg/0.3mg) are likely unsuitable for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Venuvi GM 2mg/500mg/0.3mg Tablet SR, as its use may be unsafe. A physician's consultation is advised. Furthermore, this medication is contraindicated for those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Venuvi GM 2mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Venuvi GM 2mg/500mg/0.3mg Tablet SR :

Should you forget a dose of Venuvi GM 2mg/500mg/0.3mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Venuvi GM 2mg/500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Venuvi GM 2mg/500mg/0.3mg Tablet SR

Venuvi GM SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-action therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Venuvi GM 2mg/500mg/0.3mg SR Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, abdominal pain, headache, rash, and respiratory infections.
Venuvi GM 2mg/500mg/0.3mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Venuvi GM 2mg/500mg/0.3mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Venuvi GM 2mg/500mg/0.3mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Venuvi GM 2mg/500mg/0.3mg...
89
MRP 109
18% off